Chemoinformaics analysis of Nonacosanoic acid
Molecular Weight | 438.781 | nRot | 27 |
Heavy Atom Molecular Weight | 380.317 | nRig | 24 |
Exact Molecular Weight | 438.444 | nRing | 0 |
Solubility: LogS | -2.81 | nHRing | 0 |
Solubility: LogP | 1.376 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 89 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 58 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 29 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 88.708 |
nHD | 1 | BPOL | 59.054 |
QED | 0.821 |
Synth | 6.438 |
Natural Product Likeliness | 2.407 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.472 |
Pgp-sub | 0.667 |
HIA | 0.364 |
CACO-2 | -5.086 |
MDCK | 0.0000349 |
BBB | 0.232 |
PPB | 0.0961997 |
VDSS | 1.41 |
FU | 0.778668 |
CYP1A2-inh | 0.014 |
CYP1A2-sub | 0.814 |
CYP2c19-inh | 0.062 |
CYP2c19-sub | 0.947 |
CYP2c9-inh | 0.015 |
CYP2c9-sub | 0.195 |
CYP2d6-inh | 0.01 |
CYP2d6-sub | 0.704 |
CYP3a4-inh | 0.283 |
CYP3a4-sub | 0.917 |
CL | 7.078 |
T12 | 0.051 |
hERG | 0.718 |
Ames | 0.812 |
ROA | 0.625 |
SkinSen | 0.125 |
Carcinogencity | 0.763 |
EI | 0.005 |
Respiratory | 0.905 |
NR-Aromatase | 0.927 |
Antiviral | No |
Prediction | 0.631678 |